Still A COVID-19 Game Changer? UK’s Cautious Launch Of MSD’s Antiviral Lagevrio

Efficacy In Vaccinated Population Unproven

 
• By Andrew McConaghie

The oral therapy is likely to be a useful addition to the COVID-19 armamentarium, but hopes of it being a ‘game changer’ now look overly optimistic.  

UK oovid December 2021
The Lagevrio study coincides with the UK re-introducing social distancing measures to limit the effects of the new Omicron variant. • Source: Getty Images

More from Clinical Trials

More from R&D